Added to YB: 2026-06-25
Pitch date: 2026-06-23
SFZN.SW [neutral]
Siegfried Holding AG
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
Market Cap
CHF 3.0B
Pitch Price
N/A
Price Target
N/A
Dividend
0.58%
EV/EBITDA
11.27
P/E
17.85
EV/Sales
2.62
Sector
Life Sciences Tools and Services
Category
growth
Siegfried (SFZN Switzerland): Acquisitions are setting up a stronger second half
SFZN.SW (update): Swiss CDMO facing soft H1 2026 on FX & temporary customer order gap in Drug Substances; Drug Products growing steadily. Mgmt maintains ~8% constant-FX rev growth guidance w/ H2 acceleration. Noramco/Purisys/Extractas APImulti acquisitions expand small-molecule footprint. Selloff on CFO transition & weak H1 seen as disconnected from intact outlook.
Read full article (2 min)